Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cell Thera Tries Bait-and-Switch With Opaxio
TheStreet.com
Tuesday, September 22, 2009 - 9:18am
tags:
Opaxio, Cell Therapeutics, lung cancer
Oxford Bio's failed cancer vaccine may help some
Reuters
Tuesday, September 22, 2009 - 9:16am
tags:
Oxford BioMedica, vaccines, cancer
Buying binge hits biotech firms
Boston Globe, MA
Tuesday, September 22, 2009 - 9:03am
tags:
biotech, Facet Biotech, M&A, Biogen Idec, Inverness Medical, Sepracor
Facet advises 'no action' on Biogen bid
Bizjournals.com
Tuesday, September 22, 2009 - 8:48am
tags:
Facet Biotech, Biogen Idec, M&A
Valeant Works On Base After Price Pullback
Yahoo/Investors Business Daily
Tuesday, September 22, 2009 - 8:39am
tags:
Valeant Pharmaceuticals
Glaxo Could Find Reasons to Extend Its Alliance with Dr. Reddy's
Seeking Alpha
Tuesday, September 22, 2009 - 8:34am
tags:
GSK, Dr Reddy's, partnerships
Pfizer, Wyeth selling animal health assets to Boehringer as they try to close buyout deal
Yahoo/AP
Monday, September 21, 2009 - 6:31pm
tags:
Pfizer, Wyeth, Boehringer Ingelheim, veterinary medicine, animal health
Effient and Onglyza Launches "Sluggish"; Multaq More Hopeful
BNET Pharma
Monday, September 21, 2009 - 5:23pm
tags:
Effient, Onglyza, diabetes, Eli Lilly, AstraZeneca, Bristol-Myers Squibb
Lilly Reaches Zyprexa Agreement With Seven States
Bloomberg
Monday, September 21, 2009 - 5:18pm
tags:
Eli Lilly, Zyprexa, settlements
Inhibitex Initiated at Neutral with Significant Upside Potential
Seeking Alpha
Monday, September 21, 2009 - 4:52pm
tags:
Inhibitex, pipelines
Adolor Acquires Rights to Clinical-Stage Product Candidate from Eli Lilly and Company
Yahoo
Monday, September 21, 2009 - 4:50pm
tags:
Adolor, liscensing, OpRA III, Eli Lilly
FDA approves J&J's Cypher stent for use in smaller blood vessels
Yahoo/AP
Monday, September 21, 2009 - 4:48pm
tags:
FDA, JNJ, stents, Cypher
Drugmaker Merck seeks EU approval for $41B acquisition of Schering-Plough, expects ruling soon
Yahoo/AP
Monday, September 21, 2009 - 4:47pm
tags:
Merck, EU, Europe, Schering Plough, M&A
GlaxoSmithKline bans political donations, alters spending rules on doctor training, consulting
Yahoo/AP
Monday, September 21, 2009 - 10:52am
tags:
GSK, physicians, physician payments
Biotech News Bytes: Neuralstem, Questcor, Valeant, Impax
Seeking Alpha
Monday, September 21, 2009 - 10:48am
tags:
Neuralstem, Questcor Pharmaceuticals, Valeant Pharmaceuticals, Impax
Perrigo buys KV Pharma filing for generic acne gel
Reuters
Monday, September 21, 2009 - 10:35am
tags:
KV Pharmaceutical, Perrigo Company, acne
Alzheimer’s, Dementia Rise Faster Than Expected, Report Says
Bloomberg
Monday, September 21, 2009 - 10:19am
tags:
Alzheimer's disease, dementia
Arena's Lorcaserin Has Safety Edge
Yahoo/Zacks.com
Monday, September 21, 2009 - 10:10am
tags:
Arena Pharmaceuticals, lorcaserin, obesity, Vivus, Orexigen
AstraZeneca gets rights to 2 Nektar pain drug candidates in deal valued at about $1.12B
Yahoo/AP
Monday, September 21, 2009 - 9:57am
tags:
AstraZeneca, Nektar
Biogen Idec Makes Bid for Facet for $14.50 a Share
Bloomberg
Monday, September 21, 2009 - 9:56am
tags:
Biogen Idec, Facet Biotech, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.